Table 7 Logistic regression analysis
Variables | OR (95% CI) | p-value |
|---|---|---|
Gender | ||
Female | 1 (0.7–1.6) | 0.7 |
Age categories | ||
≤ 30 | Reference | |
31–40 | 0.8 (0.4–1.7) | 0.6 |
41–50 | 1.4 (0.8–2.6) | 0.3 |
> 50 | 1 (0.6–1.7) | 1 |
Overall prescribed drugs | ||
≤ 5 | Reference | |
6–7 | 3.5 (0.9–12.9) | 0.07 |
8–9 | 8.9 (2.6–30.3) | <0.001 |
≥ 10 | 25.2 (7.7–82.2) | <0.001 |
QT drugs | ||
1 | Reference | |
2 | 25.4 (11.2–57.5) | <0.001 |
≥ 3 | 21 (9.2–48) | <0.001 |
Diagnoses | ||
Acute lymphoblastic leukemia | Reference | |
Breast cancer | 3.7 (1.2–11.6) | 0.03 |
Chronic lymphocytic leukemia | 3.5 (0.8–15.9) | 0.1 |
Gastrointestinal cancer | 4 (1.3–13) | 0.02 |
Genitourinary cancer | 2.7 (0.7–10.9) | 0.2 |
Gynecologic cancer | 3.1 (0.9–11.2) | 0.08 |
Musculoskeletal cancer | 2.5 (0.5–12) | 0.3 |
Non hodgkin lymphoma | 0.3 (0.07–1.3) | 0.1 |
Others | 1 (0.3–3.3) | 0.9 |
Anticancer drugs | ||
≤ 2 | Reference | |
> 2 | 0.6 (0.4–0.9) | 0.02 |
Supportive care drugs | ||
≤ 3 | Reference | |
4–5 | 4.3 (1.9–9.5) | <0.001 |
6–8 | 8.1 (3.7–17.7) | <0.001 |
> 8 | 12.2 (4.9–30.5) | <0.001 |